Literature DB >> 7492608

Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.

Z Kiss1, M Tomono.   

Abstract

Tricyclodecan-9-yl-xanthogenate (compound D609) has recently been used in various cellular systems to specifically inhibit the activity of phosphatidylcholine (PtdCho)-directed phospholipase C (PLC). Here we show that in intact NIH 3T3 fibroblasts, concentrations of D609 (35 to 50 micrograms/ml) which have been used to inhibit PLC activity also significantly inhibit phorbol ester-induced phospholipase D-mediated hydrolysis of both PtdCho and phosphatidylethanolamine (PtdEtn). In addition, in isolated membranes compound D609 also inhibited PLC-mediated PtdEtn hydrolysis. The results indicate that compound D609 cannot be considered as a specific inhibitor of PtdCho-directed PLC activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492608     DOI: 10.1016/0005-2760(95)00148-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Involvement of diacylglycerol production in activation of nuclear factor kappaB by a CD14-mediated lipopolysaccharide stimulus.

Authors:  H Yamamoto; K Hanada; M Nishijima
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells.

Authors:  I Plo; D Lautier; T Levade; H Sekouri; J P Jaffrézou; G Laurent; A Bettaïeb
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Regulation of phosphatidylethanolamine degradation by enzyme(s) of subcellular fractions from cerebral cortex.

Authors:  J Strosznajder
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 4.  Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; A Gusain
Journal:  Neurochem Res       Date:  2011-11-22       Impact factor: 3.996

5.  Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway.

Authors:  J T Neary; Y Kang; Y Bu; E Yu; K Akong; C M Peters
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

6.  The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen.

Authors:  G Lozanski; F Berthier; I Kushner
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

9.  Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons.

Authors:  Thuy-Vi V Nguyen; Mingzhong Yao; Christian J Pike
Journal:  Brain Res       Date:  2009-08-31       Impact factor: 3.252

10.  The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes.

Authors:  Delphine Milhas; Nathalie Andrieu-Abadie; Thierry Levade; Hervé Benoist; Bruno Ségui
Journal:  Int J Mol Sci       Date:  2012-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.